| V03AB21 |
V03AB21 potassium iodide |
| V03AB22 |
V03AB22 amyl nitrite |
| V03AB23 |
V03AB23 acetylcysteine |
| V03AB24 |
V03AB24 digitalis antitoxin |
| V03AB25 |
V03AB25 flumazenil |
| V03AB26 |
V03AB26 methionine |
| V03AB27 |
V03AB27 4-dimethylaminophenol |
| V03AB29 |
V03AB29 cholinesterase |
| V03AB31 |
V03AB31 prussian blue |
| V03AB32 |
V03AB32 glutathione |
| V03AB33 |
V03AB33 hydroxocobalamin |
| V03AB34 |
V03AB34 fomepizole |
| V03AB35 |
V03AB35 sugammadex |
| V03AB36 |
V03AB36 phentolamine |
| V03AB37 |
V03AB37 idarucizumab |
| V03AB38 |
V03AB38 Andexanet Alfa |
| V03AC |
V03AC Iron chelating agents |
| V03AC01 |
V03AC01 Deferoxamine |
| V03AC02 |
V03AC02 deferiprone |
| V03AC03 |
V03AC03 Deferasirox |
| V03AE |
V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AE01 |
V03AE01 polystyrene sulfonate |
| V03AE02 |
V03AE02 Sevelamer |
| V03AE03 |
V03AE03 Lanthanum carbonate |
| V03AE04 |
V03AE04 Calcium acetate and magnesium carbonate |
| V03AE05 |
V03AE05 sucroferric oxyhydroxide |
| V03AE06 |
V03AE06 colestilan |
| V03AE07 |
V03AE07 calcium acetate |
| V03AE08 |
V03AE08 ferric citrate |
| V03AE09 |
V03AE09 patiromer calcium |